| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |